Showing results (21-30 of 276) with videos related to

Sort By:
Pageof 28
Cancers|November 27, 2021
Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?Paul DiSilvestro, Nicoletta Colombo, Philipp Harter, et al.
Expert Opinion on Biological Therapy|January 19, 2011
Abagovomab for ovarian cancerJacobus Pfisterer, Philipp Harter, Cecilia Simonelli, et al.
Cancer|January 23, 2020
How to manage lymph nodes in ovarian cancerPhilipp Harter, Florian Heitz, Beyhan Ataseven, et al.
Cancer|February 4, 2009
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)Andreas du Bois, Alexander Reuss, Eric Pujade-Lauraine, et al.
Gynecologic Oncology|December 23, 2015
Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IVBeyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Prognostic factors for complete debulking in first- and second-line ovarian cancerPhilipp Harter, Felix Hilpert, Sven Mahner, et al.
Cancer|January 22, 2009
Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patientsChristian Walter, Bilal Al-Nawas, Andreas du Bois, et al.
Gynecologic Oncology|October 15, 2014
Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancerBeyhan Ataseven, Christoph Grimm, Philipp Harter, et al.
Virchows Archiv : an International Journal of Pathology|January 28, 2009
Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)Stefan Kommoss, Dietmar Schmidt, Friedrich Kommoss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trialsAndreas du Bois, Alexander Reuss, Philipp Harter, et al.
Pageof 28